Evolution of a Protocol for Ketamine-induced Sedation as an Alternative to General Anesthesia for Interventional Radiologic Procedures in Pediatric Patients

PURPOSE: To establish a protocol for credentialed pediatric radiology nurses, with radiologist supervision, to administer ketamine to induce sedation and analgesia during interventional radiologic procedures.

MATERIALS AND METHODS: This study was conducted in two phases. The goal of the first phase was to develop a sedation protocol to replace that of using general anesthesia for specified pediatric interventional procedures. Ketamine was administered intravenously (with intermittent bolus or continuous infusion) or intramuscularly. Sedation induction times, adverse events, doses, and sedation and recovery durations were recorded. In phase 2, the results of phase 1 were reviewed and a formal ketamine protocol was developed.

RESULTS: Neither sedation failures nor substantial adverse events occurred in phase 1. Mean duration of all sedations was 52 minutes, and median recovery room time was 0 minutes. In phase 2, the results of phase 1 were reviewed and a sedation protocol was proposed to a hierarchy of hospital committees before final approval from the medical staff executive committee. Subsequently, standard order forms for radiology nurse administration of ketamine with radiologist supervision were prepared for exclusive use by the pediatric interventional radiology department.

CONCLUSION: Ketamine-induced sedation may be a safe and effective alternative to general anesthesia for some interventional radiologic procedures in pediatric patients. Collaboration between anesthesia and radiology departments is important for development of a safe and successful ketamine sedation program. To the authors’ knowledge, this is the first report describing the intravenous infusion of ketamine for sedation in pediatric patients and the only report describing the establishment of a protocol for ketamine administration by credentialed radiology nurses with radiologist supervision.

© RSNA, 2002

References

  • 1 White PF. Ketamine update: its clinical uses in anesthesia. Semin Anesth 1998; 7:113-126. Google Scholar
  • 2 Way WL, Trevor AJ. Pharmacology of intravenous nonnarcotic anesthetics. In: Miller RD, eds. Anesthesia. 2nd ed. Vol 2. New York, NY: Churchill Livingstone, 1986; 813-817. Google Scholar
  • 3 Drummond GB. Comparison of sedation with midazolam and ketamine: effects on airway muscle activity. Br J Anaesth 1996; 76:663-667. Crossref, MedlineGoogle Scholar
  • 4 Dachs RJ, Innes GM. Intravenous ketamine sedation for pediatric patients in the emergency department. Ann Emerg Med 1997; 29:146-150. Crossref, MedlineGoogle Scholar
  • 5 Marx CM, Stein J, Tyler MK, Nieder ML, Shurin SB, Blumer JL. Ketamine-midazolam versus meperidine-midazolam for painful procedures in pediatric oncology patients. J Clin Oncol 1997; 15:94-102. Crossref, MedlineGoogle Scholar
  • 6 Roelofse JA, Joubert JJ, Roelofse PG. A double-blind randomized comparison of midazolam alone and midazolam combined with ketamine for sedation of pediatric dental patients. J Oral Maxillofac Surg 1996; 54:838-844. Crossref, MedlineGoogle Scholar
  • 7 Bennett JA, Bullimore JA. The use of ketamine hydrochloride anaesthesia for radiotherapy in young children. Br J Anaesth 1973; 45:197-201. Crossref, MedlineGoogle Scholar
  • 8 Cotsen MR, Donaldson JS, Uejima T, Morello FP. Efficacy of ketamine hydrochloride sedation in children for interventional radiologic procedures. AJR Am J Roentgenol 1997; 169:1019-1022. Crossref, MedlineGoogle Scholar
  • 9 American Academy of Pediatrics Committee on Drugs. Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992; 89:1110-1115. MedlineGoogle Scholar
  • 10 Armitage P, Berry G. Statistical methods in medical research 3rd ed. Cambridge, Mass: Blackwell Science, 1994; 394-400. Google Scholar
  • 11 Conover WJ. Practical nonparametric statistics 3rd ed. New York, NY: Wiley, 1999; 271-80. Google Scholar
  • 12 Green SM, Clem KJ, Rothrock SG. Ketamine safety profile in the developing world: survey of practitioners. Acad Emerg Med 1996; 3:598-604. Crossref, MedlineGoogle Scholar
  • 13 Green SM, Rothrock SG, Lynch EL, et al. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med 1998; 31:688-697. Crossref, MedlineGoogle Scholar
  • 14 Fine J, Fubestone SC. Sensory disturbances following ketamine anesthesia: recurrent hallucinations. Anesth Analg 1973; 52:428-430. Crossref, MedlineGoogle Scholar
  • 15 Meyers EF, Charles P. Prolonged adverse reactions to ketamine in children. Anesthesiology 1978; 49:39-40. Crossref, MedlineGoogle Scholar
  • 16 Roelofse JA, Joubert JJ, Roelofse PG. A double-blind randomized comparison of midazolam alone and midazolam combined with ketamine for sedation of pediatric dental patients. J Oral Maxillofac Surg 1996; 54:838-844. Crossref, MedlineGoogle Scholar
  • 17 Sherwin TS, Green SM, Khan A, Chapman DS, Danneberg B. Does adjunctive midazolam reduce recovery agitation after ketamine sedation for pediatric procedures? A randomized double-blind, placebo-controlled trial. Ann Emerg Med 2000; 35:229-238. Crossref, MedlineGoogle Scholar
  • 18 Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med 2000; 36:579-588. Crossref, MedlineGoogle Scholar
  • 19 Hollister GR, Burn JM. Side effects of ketamine in pediatric anesthesia. Anesth Analg 1974; 53:262-267. Google Scholar
  • 20 Green SM, Johnson NE. Ketamine sedation for pediatric procedures: part 2, review and implications. Ann Emerg Med 1990; 19:1033-1046. Crossref, MedlineGoogle Scholar
  • 21 Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med 2000; 36:579-588. Crossref, MedlineGoogle Scholar
  • 22 Sussman DR. A comparative evaluation of ketamine anesthesia in children and adults. Anesthesiology 1974; 40:459-464. Crossref, MedlineGoogle Scholar
  • 23 Pruitt JW, Goldwasser MS, Sabol SR, Prstojevich SJ. Intramuscular ketamine, midazolam, and glycopyrrolate for pediatric sedation in the emergency department. J Oral Maxillofac Surg 1995; 53:13-17. Crossref, MedlineGoogle Scholar
  • 24 Green SM, Rothrock SG, Lynch EL, et al. Intramuscular ketamine for pediatric sedation in the emergency department: safety profile in 1,022 cases. Ann Emerg Med 1998; 31:688-697. Crossref, MedlineGoogle Scholar
  • 25 Sagratella S. NMDA antagonists: antiepileptic-neuroprotective drugs with diversified neuropharmacological profiles. Pharmacol Res 1995; 32:1-13. Crossref, MedlineGoogle Scholar
  • 26 Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1980; 36:186-197. Google Scholar
  • 27 Chen KB, Tu KT, Cheng HC, Wu YL, Chang JS. The anesthetic management of a preterm infant weighing 500 grams undergoing ligation of patent ductus arteriosus: a case report. Acta Anaesthesiol Sin 1999; 37:89-92. MedlineGoogle Scholar
  • 28 Tugrul M, Camci E, Pembeci K, Telci L, Akpir K. Ketamine infusion versus isoflurane for the maintenance of anesthesia in the prebypass period in children with tetralogy of Fallot. J Cardiothoracic Anesth 2000; 14:557-561. CrossrefGoogle Scholar

Article History

Published in print: Nov 2002